Experiencia clínica en España con la vacuna combinada hexavalente DTPa-HB-IPV/Hib de GlaxoSmithKline (Infanrix Hexa®)
Leído
14686
Vecesse ha leído el artículo
2861
Total PDF
11825
Total HTML
Información del artículo
ISSN: 16954033Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 50 | 11 | 61 |
| 2025 5 | 273 | 52 | 325 |
| 2025 4 | 199 | 56 | 255 |
| 2025 3 | 164 | 36 | 200 |
| 2025 2 | 178 | 34 | 212 |
| 2025 1 | 162 | 45 | 207 |
| 2024 12 | 114 | 37 | 151 |
| 2024 11 | 103 | 53 | 156 |
| 2024 10 | 106 | 47 | 153 |
| 2024 9 | 87 | 41 | 128 |
| 2024 8 | 116 | 63 | 179 |
| 2024 7 | 89 | 50 | 139 |
| 2024 6 | 91 | 40 | 131 |
| 2024 5 | 83 | 36 | 119 |
| 2024 4 | 85 | 47 | 132 |
| 2024 3 | 71 | 47 | 118 |
| 2024 2 | 73 | 67 | 140 |
| 2024 1 | 102 | 44 | 146 |
| 2023 12 | 74 | 36 | 110 |
| 2023 11 | 94 | 40 | 134 |
| 2023 10 | 77 | 38 | 115 |
| 2023 9 | 69 | 34 | 103 |
| 2023 8 | 60 | 32 | 92 |
| 2023 7 | 87 | 42 | 129 |
| 2023 6 | 72 | 46 | 118 |
| 2023 5 | 118 | 54 | 172 |
| 2023 4 | 50 | 31 | 81 |
| 2023 3 | 87 | 42 | 129 |
| 2023 2 | 76 | 20 | 96 |
| 2022 1 | 69 | 30 | 99 |
| 2022 12 | 59 | 21 | 80 |
| 2022 11 | 104 | 52 | 156 |
| 2022 10 | 88 | 44 | 132 |
| 2022 9 | 110 | 34 | 144 |
| 2022 8 | 82 | 43 | 125 |
| 2022 7 | 57 | 31 | 88 |
| 2022 6 | 49 | 31 | 80 |
| 2022 5 | 54 | 45 | 99 |
| 2022 4 | 64 | 38 | 102 |
| 2022 3 | 79 | 41 | 120 |
| 2022 2 | 76 | 29 | 105 |
| 2021 1 | 101 | 37 | 138 |
| 2021 12 | 66 | 55 | 121 |
| 2021 11 | 77 | 51 | 128 |
| 2021 10 | 91 | 59 | 150 |
| 2021 9 | 73 | 54 | 127 |
| 2021 8 | 66 | 29 | 95 |
| 2021 7 | 81 | 33 | 114 |
| 2021 6 | 93 | 28 | 121 |
| 2021 5 | 102 | 23 | 125 |
| 2021 4 | 200 | 105 | 305 |
| 2021 3 | 111 | 37 | 148 |
| 2021 2 | 104 | 28 | 132 |
| 2020 1 | 110 | 25 | 135 |
| 2020 12 | 124 | 12 | 136 |
| 2020 11 | 94 | 15 | 109 |
| 2020 10 | 73 | 21 | 94 |
| 2020 9 | 85 | 15 | 100 |
| 2020 8 | 114 | 10 | 124 |
| 2020 7 | 97 | 10 | 107 |
| 2020 6 | 131 | 14 | 145 |
| 2020 5 | 111 | 15 | 126 |
| 2020 4 | 92 | 20 | 112 |
| 2020 3 | 56 | 14 | 70 |
| 2020 2 | 94 | 16 | 110 |
| 2020 1 | 60 | 18 | 78 |
| 2019 12 | 53 | 16 | 69 |
| 2019 11 | 68 | 8 | 76 |
| 2019 10 | 64 | 22 | 86 |
| 2019 9 | 90 | 14 | 104 |
| 2019 8 | 85 | 31 | 116 |
| 2019 7 | 70 | 13 | 83 |
| 2019 6 | 144 | 21 | 165 |
| 2019 5 | 202 | 17 | 219 |
| 2019 4 | 141 | 24 | 165 |
| 2019 3 | 88 | 10 | 98 |
| 2019 2 | 65 | 14 | 79 |
| 2019 1 | 73 | 12 | 85 |
| 2018 12 | 61 | 22 | 83 |
| 2018 11 | 79 | 20 | 99 |
| 2018 10 | 104 | 17 | 121 |
| 2018 9 | 39 | 14 | 53 |
| 2018 8 | 2 | 0 | 2 |
| 2018 7 | 5 | 0 | 5 |
| 2018 6 | 7 | 0 | 7 |
| 2018 5 | 10 | 0 | 10 |
| 2018 4 | 44 | 0 | 44 |
| 2018 3 | 43 | 0 | 43 |
| 2018 2 | 40 | 0 | 40 |
| 2018 1 | 32 | 0 | 32 |
| 2017 12 | 36 | 0 | 36 |
| 2017 11 | 44 | 0 | 44 |
| 2017 10 | 45 | 0 | 45 |
| 2017 9 | 44 | 0 | 44 |
| 2017 8 | 41 | 1 | 42 |
| 2017 7 | 45 | 3 | 48 |
| 2017 6 | 67 | 22 | 89 |
| 2017 5 | 83 | 10 | 93 |
| 2017 4 | 53 | 10 | 63 |
| 2017 3 | 49 | 8 | 57 |
| 2017 2 | 207 | 6 | 213 |
| 2016 1 | 75 | 3 | 78 |
| 2016 12 | 72 | 7 | 79 |
| 2016 11 | 96 | 9 | 105 |
| 2016 10 | 119 | 30 | 149 |
| 2016 9 | 160 | 9 | 169 |
| 2016 8 | 86 | 5 | 91 |
| 2016 7 | 37 | 7 | 44 |
| 2016 3 | 1 | 0 | 1 |
| 2015 9 | 1 | 0 | 1 |
| 2015 8 | 2 | 0 | 2 |
| 2015 7 | 2 | 0 | 2 |
| 2015 6 | 1 | 0 | 1 |
| 2015 5 | 2 | 0 | 2 |
| 2015 4 | 1 | 0 | 1 |
| 2015 3 | 2 | 0 | 2 |
| 2015 2 | 1 | 0 | 1 |
| 2015 1 | 6 | 0 | 6 |
| 2014 12 | 17 | 0 | 17 |
| 2014 11 | 22 | 1 | 23 |
| 2014 10 | 19 | 0 | 19 |
| 2014 9 | 12 | 0 | 12 |
| 2014 8 | 21 | 2 | 23 |
| 2014 7 | 32 | 1 | 33 |
| 2014 6 | 47 | 3 | 50 |
| 2014 5 | 31 | 3 | 34 |
| 2014 4 | 30 | 2 | 32 |
| 2014 3 | 45 | 2 | 47 |
| 2014 2 | 33 | 5 | 38 |
| 2014 1 | 30 | 2 | 32 |
| 2013 12 | 35 | 2 | 37 |
| 2013 11 | 19 | 2 | 21 |
| 2013 10 | 62 | 4 | 66 |
| 2013 9 | 34 | 12 | 46 |
| 2013 8 | 32 | 10 | 42 |
| 2013 7 | 22 | 1 | 23 |
| 2003 6 | 1988 | 0 | 1988 |
Mostrar todo
